Carregant...
Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost Effectiveness and Health Impact in U.S. Populations
INTRODUCTION: Recommending both the conjugate and polysaccharide pneumococcal vaccines to all U.S. seniors may have little public health impact and be economically unreasonable. Public health impact and cost effectiveness of using both vaccines in all adults aged ≥65 years were estimated compared wi...
Guardat en:
| Publicat a: | Am J Prev Med |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7089827/ https://ncbi.nlm.nih.gov/pubmed/32001052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2019.10.022 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|